Copyright
©The Author(s) 2024.
World J Med Genet. Sep 20, 2024; 12(1): 93011
Published online Sep 20, 2024. doi: 10.5496/wjmg.v12.i1.93011
Published online Sep 20, 2024. doi: 10.5496/wjmg.v12.i1.93011
Cancer | circRNA | Expression | Function/target | Ref. |
Lung cancer | hsa_circ_0005962 | Up | Promotes proliferation; non-invasive diagnostic biomarker | [80] |
hsa_circ_0086414 | Down | Cancer progression; non-invasive diagnostic biomarker | [80] | |
hsa_circ_0102537 | Down | Biomarker for diagnosis; fluid shear stress and PI3K-Akt signaling pathway | [81] | |
hsa_circ_0000190 | Up | Tumorigenesis and immune evasion; facilitates tumorigenesis and immune evasion by upregulating the Expression of soluble PD-L1 in non-small-cell lung cancer | [82] | |
CDR1as | Up | Enduring growth signaling; regulating miR-219a-5p/SOX5 axis | [83] | |
hsa_circ_0001715 | Up | Distant metastasis; potential diagnostic and prognostic Biomarker | [84] | |
circPTK2 | Down | Activating invasion and metastasis; inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ | [85] | |
circ_0067934 | Up | Activating invasion and metastasis; regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway | [86] | |
hsa_circ_0012673 | Up | Cancer cell proliferation and invasion; via miR-320a/LIMK18521 axis | [87] | |
F-circEA-2a | Up | Promotes cell migration and invasion | [88] | |
F-circEA | Up | Promotes cell migration and invasion; potential diagnostic value | [89] | |
circRNA_100876 | Up | Distant metastasis; potential prognostic biomarker and therapeutic target | [90] | |
circRNA_ZEB1/hsa_circ_0023404 | Up | Promotes proliferation, migration, and invasion; regulating miR-217/ZEB1 axis | [91] | |
CiRS-7 | Up | Increased proliferation, migration, and invasion, yet reduced apoptosis; targets NF-κB signaling | [92] | |
HCC | has_circ_0001445 | Up | Regulates proliferation and migration; targets miR-942-5p/ALX4 axis | [93] |
has_circ_0027089 | Up | Biomarker for diagnosis of hepatitis-related HCC | [94] | |
has_circ_0016788 | Up | Evading growth inhibitors; targets miR-486/CDK4 pathway | [95] | |
circ-SMARCA5 | Down | Inhibits cell proliferation and promotes apoptosis; potential prediction and monitoring biomarker for HCC | [96] | |
circSMAD2 | Down | Activating invasion and metastasis; inhibits epithelial-mesenchymal transition by targeting miR-629 | [97] | |
has_circ_0064428 | Down | Immune-associated prognostic biomarker for HCC patients | [98] | |
has_circ_0009582; circ_0037120 | Up | Biomarker for diagnosis | [99] | |
has_circ_0140117 | Up | Potential biomarkers for predicting occurrence of HCC | [99] | |
CDR1as | Up | Cell proliferation and migration; enduring growth signaling | [100] | |
Gastric cancer | has_circ_0010882 | Up | Role in proliferation, migration, and invasive phenotypes; regulation of PI3K/Akt/mTOR signaling | [101] |
has_circ_0001017 | Down | Cell proliferation, migration, and invasion; sponge of miR-197 | [102] | |
has_circ_0061276; hsa_circ_0001017 | Down | Potential prognostic tumor biomarkers | [103] | |
has_circ_0000745 | Down | Regulating GC growth and migration; promising diagnostic biomarker | [104] | |
circ-Rangap1 | Up | Cancer invasion and metastasis; targeting miR-877-3p | [105] | |
has_circ_0000181 | Up | Distant metastasis and TNM stage; diagnostic biomarker | [106] | |
circ-PSMC3 | Down | Cell proliferation and metastasis | [107] | |
circ-LMTK2 | Down | |||
circ-DLST | Up | |||
circ-KIAA1244 | Down | TNM stage and lymphatic metastasis | [108] | |
circ-ZFR | Down | Evading growth inhibitors; sponging miR-130a/miR-107 and modulating PTEN | [109] | |
CDR1as | Down | Evading growth inhibitors; targeting miR-876-5p/GNG7 axis | [110] | |
circRNA-000425 | Down | Evading growth inhibitors; proliferation, apoptosis, and cell drug sensitivity via YAP1-induced tumorigenesis | [111] | |
circRNA_0023642 | Up | Activating invasion and metastasis; regulating epithelial-mesenchymal transition | [112] | |
has_circ_0001178 | Up | Invasion and metastasis; via sponging multiple miRNAs | [113] | |
has_circ_0005927 | Down | Cell colony-forming ability, migration, and invasion; regulating miR-942-5p/BATF2 axis | [114] | |
has_circ_0082182 | Up | Drug resistance and cancer progression; sponging miR-326 | [115] | |
hsa_circ_0082182, hsa_circ_0000370 | Up | Inhibit apoptosis; potential diagnostic markers | [116] | |
has_circ_0035445 | Up | Promotes proliferation and migration but suppresses apoptosis; potential diagnostic marker | [116] | |
has_circ_0006990 | Up | Cancer progression; via mediation of hsa_circ_0006990/miR-132-3p/MUC13 axis | [117] | |
CDR1as | Up | Enduring growth signaling; regulating microRNA-7 | [118] | |
circHIPK3 | Up | Enduring growth signaling; sponging miR-7 | [119] | |
hsa_circ_0007534 | Up | Blocking apoptosis | [120] | |
hsa_circRNA_103809 | Down | Cell proliferation and migration; via miR-532-3p/FOXO4 axis | [121] | |
hsa-circ-0020397 | Up | Regulates CRC cell viability, apoptosis, and invasion by promoting the expression of miR-138 target genes | [121] | |
Breast cancer | hsa_circ_0001785 | Up | Proliferation, migration, and invasion; potential diagnostic value | [122] |
hsa_circ_0008673 | Up | Prognostic predictor of OS and DSS | [122] | |
circ-ITCH | Down | Evading growth inhibitors; targets Wnt/β-catenin pathway | [123] | |
hsa_circ_0104824 | Down | Cell migration, cell-cell adhesion, and proliferation; promising predictive biomarker and therapeutic target | [124] | |
Esophageal cancer | circ-TTC17 | Up | Promotes proliferation and migration; novel biomarker for diagnosis, treatment, and prognosis | [125] |
hsa_circ_0007203 (circ-DLG1) | Up | Promotes cell proliferation | [126] | |
hsa_circ_0004771 | Up | Diagnostic biomarker; targets via miR-339-5p/CDC25A axis | [127] | |
circGSK3β | Up | Promoting metastasis; augmenting β-catenin signaling | [128] | |
circ-SLC7A5 | Up | Regulator of tumorigenesis and metastasis | [129] | |
Pancreatic cancer | circ-LDLRAD3 | Up | Proliferation, migration and invasion; via miR-137-3p/PTN axis | [130,131] |
circNFIB1, hsa_circ_0086375 | Down | Lymphangiogenesis and lymphatic metastasis; via miR-486-5p/PIK3R1/VEGF-C axis | [132] | |
Thyroid cancer | has_circ_0124055 | Up | Regulates proliferation and apoptosis: Prognostic and diagnostic indicator | [133] |
has_circ_0101622 | Up | Regulates proliferation and apoptosis: Prognostic and diagnostic indicator | [133] | |
Gallbladder cancer | circ-MTO1 | Up | Early diagnostic and prognostic marker | [134] |
circHIPK3 | Up | Evading growth inhibitors; sponging miR-124 | [135] | |
Ovarian/endometrial cancer | has_circ_0078607 | Up | Adverse prognostic indicator for ovarian cancer; regulating miR-32-5p/SIK1 network | [136] |
has_circ_0061140 | Up | Activating invasion and metastasis; targeting miR-197/high mobility group protein A1 axis in endometrial cancer | [137] | |
Glioma/glioblastoma | hsa_circ_0046701 | Up | Enduring growth signaling; critical regulatory roles via hsa_circ_0046701/miR-142-3p/ITGB8 axis | [138] |
circ-FBXW7 | Down | Enduring growth signaling; potential prognostic implications | [139] | |
circNFIX | Up | Blocking apoptosis; regulating miR-378e/RPN2 axis | [140] | |
cZNF292 | Up | Promoting angiogenesis; Wnt/β-catenin signaling | [141] |
- Citation: Sharma A, Bansal C, Sharma KL, Kumar A. Circular RNA: The evolving potential in the disease world. World J Med Genet 2024; 12(1): 93011
- URL: https://www.wjgnet.com/2220-3184/full/v12/i1/93011.htm
- DOI: https://dx.doi.org/10.5496/wjmg.v12.i1.93011